To evaluate the impact of timely versus delayed antibiotic therapy on clinical outcomes in patients with Stenotrophomonas maltophilia pneumonia, highlighting its significance in improving patient care.
Key Findings:
Timely therapy had a 72.8% probability of resulting in patients being alive with fewer or no clinical events (95% CI: 67.9%–77.1%; P < .001).
Kaplan–Meier analysis showed higher survival with timely therapy (87.9% vs 65.1% for delayed therapy; log-rank P < .001).
Timely therapy reduced the death hazard with an adjusted hazard ratio of 0.48 (95% CI: .27–.86; P = .013).
Interpretation:
Timely initiation of antibiotic therapy significantly improves survival and clinical outcomes in patients with S. maltophilia pneumonia, emphasizing the need for rapid treatment in managing resistant infections to enhance patient care.
Limitations:
Retrospective design may introduce bias and confounding factors.
Study conducted at a single institution, limiting generalizability.
Conclusion:
Rapid, targeted antibiotic therapy is crucial for improving outcomes in patients with S. maltophilia pneumonia, underscoring the need for timely intervention in resistant infections.
